文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急诊科高钾血症的治疗现状及预后相关因素

[Treatment and factors associated with prognosis of hyperkalemia in the emergency department].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论急诊高钾血症中合并心功能不全与院内全因死亡升高相关(HR=1.757),达到血钾正常与利尿剂使用与死亡降低相关(HR=0.248、0.335)。

研究基于北京协和医院急诊科2019年6月1日至2020年5月31日收治的579例成人高钾血症患者(血钾≥5.5 mmol/L),按预后分为存活组与非存活组,采用单因素分析与Cox回归分析院内全因死亡的影响因素。499例(86.20%)接受降钾治疗,共44种方案,最常用为胰岛素+葡萄糖(61.3%)、利尿剂(57.2%)、碳酸氢钠(41.9%)和葡萄糖酸钙/氯化钙(44.4%);血钾越高,联合方案与血液透析使用比例越高。111例(19.20%)院内死亡;合并心功能不全预测更高死亡(HR=1.757,95%CI 1.155-2.672,P=0.009),达到血钾正常(HR=0.248,95%CI 0.155-0.398,P=0.000)与使用利尿剂(HR=0.335,95%CI 0.211-0.531,P=0.000)与更低死亡相关。

要点

  • 579例急诊高钾血症患者中111例(19.20%)院内死亡,合并心功能不全者死亡风险更高(HR=1.757,95%CI 1.155-2.672,P=0.009)
  • 达到血钾正常与院内死亡降低相关(HR=0.248,95%CI 0.155-0.398,P=0.000)
  • 使用利尿剂与院内死亡降低相关(HR=0.335,95%CI 0.211-0.531,P=0.000)
  • 急诊最常用降钾措施为胰岛素+葡萄糖(61.3%)、利尿剂(57.2%)、葡萄糖酸钙/氯化钙(44.4%)、碳酸氢钠(41.9%)
  • 轻、中、重度高钾患者联合降钾方案使用比例分别为58.4%、82.5%、94.8%,血液透析使用比例分别为9.7%、13.3%、16.0%

适用人群与场景

  • 纳入2019年6月1日至2020年5月31日北京协和医院急诊科就诊、年龄≥18岁、血清钾≥5.5 mmol/L的高钾血症患者,共579例(中位年龄64岁,四分位间距22岁;男310例占53.5%,女269例占46.5%)

诊断标准与关键阈值

  • 高钾血症定义为血清钾(K+)浓度≥5.5 mmol/L
  • 按血钾程度分为轻度317例(54.7%)、中度143例(24.7%)、重度119例(20.6%)

处置流程与药物剂量

  • 499例(86.20%)接受降钾治疗,共使用44种治疗方案
  • 常用降钾措施:胰岛素+葡萄糖(I+G)61.3%、利尿剂(Diu)57.2%、碳酸氢钠(SB)41.9%、葡萄糖酸钙/氯化钙(CA)44.4%
  • 急诊最常用的联合方案为胰岛素+葡萄糖、葡萄糖酸钙/氯化钙、利尿剂与碳酸氢钠联合(I+G+CA+Diu+SB)
  • 血钾越高,联合降钾方案和(或)血液透析(HD)使用比例越高:轻、中、重度患者联合方案使用比例分别为58.4%、82.5%、94.8%,HD使用比例分别为9.7%、13.3%、16.0%
  • 联合方案包含的降钾措施种类越多,达到血钾正常的比例越高;包含6种降钾措施的联合方案达到血钾正常比例为100%
  • 各降钾措施中血液透析达到血钾正常比例最高(93.8%)

研究设计与关键结果

  • 单中心回顾性资料提取研究,通过电子医院信息系统提取579例急诊高钾血症患者的人口学特征、基础疾病、实验室检查、降钾治疗与预后,按预后分为非存活组与存活组,采用单因素分析与Cox回归模型分析院内全因死亡的影响因素
  • 579例中男310例(53.5%)、女269例(46.5%),中位年龄64(22)岁;轻度、中度、重度高钾血症分别为317例(54.7%)、143例(24.7%)、119例(20.6%)
  • 111/579例(19.20%)院内死亡
  • Cox回归:合并心功能不全预测更高死亡(HR=1.757,95%CI 1.155-2.672,P=0.009);达到血钾正常(HR=0.248,95%CI 0.155-0.398,P=0.000)与使用利尿剂(HR=0.335,95%CI 0.211-0.531,P=0.000)与更低死亡相关

证据类型、等级与局限

  • 证据类型:基于电子医院信息系统的单中心研究,采用单因素分析与Cox回归模型
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,急诊高钾血症合并心功能不全与更高死亡率相关,达到血钾正常与死亡率降低相关;急诊降钾治疗方案多样,该研究未据此给出具体用药剂量或方案推荐

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To survey treatment and prognosis of hyperkalemia patients in the emergency department and to analyze factors associated with all-cause in-hospital mortality.

METHODS: We implemented electronic hospital information system, extracted demographic characteristics, underlying diseases, laboratory findings, potassium lowering therapy and prognosis of hyperkalemia patients [age ≥ 18 years, serum potassium (K+) concentration ≥ 5.5 mmol/L] in the emergency department of Peking Union hospital in Beijing between June 1st 2019 to May 31st 2020. The enrolled subjects were divided into the non-survival group and the survival group according to their prognosis. Univariate analysis and Cox regression model were adopted to analyze factors affecting all-cause in-hospital mortality of hyperkalemia patients.

RESULTS: A total of 579 patients [median age 64 (22) years; 310 men (53.5%) and 269 women (46.5%)] with hyperkalemia were enrolled, among which, 317 (54.7%), 143 (24.7%) and 119 (20.6%) were mild, moderate, and severe hyperkalemia, respectively. 499 (86.20%) patients received potassium-lowering therapy, forty-four treatment regimens were administered. Insulin and glucose (I+G, 61.3%), diuretics (Diu, 57.2%), sodium bicarbonate (SB, 41.9%) and calcium gluconate/chloride (CA, 44.4%) were commonly used for the treatment of hyperkalemiain the emergency department. The combination of insulin and glucose, calcium gluconate/chloride, diuretics and sodium bicarbonate (I+G+CA+Diu+SB) was the most favored combined treatment regimen of hyperkalemia in the emergency department. The higher serum potassium concentration, the higher proportion of administrating combined treatment regimen and/or hemodialysis (HD) (the proportion of administrating combined treatment regimen in mild, moderate, and severe hyperkalemia patients were 58.4%, 82.5% and 94.8%; the proportion of administrating HD in mild, moderate, and severe hyperkalemia patients were 9.7%, 13.3% and 16.0%, respectively). The proportion of achievement of normokalaemia elevated as the kinds of potassium lowering treatment included in the combined treatment regimen increased. The proportion of achievement of normokalaemia was 100% in the combined treatment regimen including 6 kinds of potassium lowering therapy. Among various potassium lowering treatments, HD contributed to the highest rate of achievement of normokalaemia (93.8%). 111 of 579 (19.20%) hyperkalemia patients died in hospital. Cox regression model revealed that complicated with cardiac dysfunction predicted higher mortality [hazard ratio (HR) = 1.757, 95% confidence interval (95%CI) was 1.155-2.672, P = 0.009]. Achievement of normokalaemia and administration of diuretics attributed to lower mortality (HR = 0.248, 95%CI was 0.155-0.398, P = 0.000; HR = 0.335, 95%CI was 0.211-0.531, P = 0.000, respectively).

CONCLUSIONS: Treatment of hyperkalemia in the emergency department were various. Complicated with cardiac dysfunction were associated with higher mortality. Achieving normokalaemia was associated with decreased mortality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wu Y, Fu Y, Tang H, et al. [Treatment and factors associated with prognosis of hyperkalemia in the emergency department]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916348. doi:10.3760/cma.j.cn121430-20220711-00653

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。